» Articles » PMID: 23442831

Determination of the Optimal Time for Premedication with Pronase, Dimethylpolysiloxane, and Sodium Bicarbonate for Upper Gastrointestinal Endoscopy

Overview
Specialty Gastroenterology
Date 2013 Feb 28
PMID 23442831
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Goals And Background: Premedication with pronase, dimethylpolysiloxane, and sodium bicarbonate improves visibility during upper gastrointestinal (UGI) endoscopy. However, the optimal time for this combination to take effect is unknown. We investigated the optimal time of pre-UGI endoscopy medication.

Study: A randomized, investigator-blind, controlled trial. The 300 patients who were to receive premedication were randomized into 3 groups according to the following medication time before UGI endoscopy: 10 minutes (group A, n=98), 10 to 30 minutes (group B, n=97), and 30 minutes premedication (group C, n=99). Visibility scores (range, 1 to 4, with lower scores indicating better gastric mucosal visibility) were assessed for the antrum, lower body, upper body, and fundus and compared, including the sum of the scores, between the 3 groups.

Results: Group B had significantly lower visibility scores for the lower body, upper body, and fundus than group C (P=0.001, 0.009, and 0.002, respectively). Group A obtained significantly lower scores for the antrum and lower body than group C (P=0.007 and 0.005, respectively). The total visibility scores of groups A and B were significantly lower compared with those of group C (P=0.001, 0.003, respectively).

Conclusions: Administration of pronase, dimethylpolysiloxane, and sodium bicarbonate within 30 minutes before UGI endoscopy significantly improved endoscopic visualization. However, the optimal time to achieve the best visibility was between 10 to 30 minutes before UGI endoscopy.

Citing Articles

Optimal timing of simethicone administration prior to upper endoscopy: A multicenter, single-blind, randomized controlled trial.

Beaufort I, Verbeek R, Bosman J, Al-Toma A, Bogte A, Alvarez Herrero L Endosc Int Open. 2023; 11(10):E992-E1000.

PMID: 37854124 PMC: 10581826. DOI: 10.1055/a-2157-5034.


Pre-medication with simethicone and N-acetyl cysteine for improving mucosal visibility during upper gastrointestinal endoscopy: A randomized controlled trial.

Nabi Z, Vamsi M, Goud R, Sayyed M, Basha J, Reddy P Indian J Gastroenterol. 2023; 43(5):986-994.

PMID: 37848768 DOI: 10.1007/s12664-023-01459-0.


Inadequate gastric preparation and its associated factors for magnetically controlled capsule endoscopy.

Kong Q, Peng C, Li Z, Tian B, Li Y, Chen F Front Pharmacol. 2023; 14:1184754.

PMID: 37701026 PMC: 10493275. DOI: 10.3389/fphar.2023.1184754.


The Effect of Using Premedication of Simethicone/Pronase With or Without Postural Change on Visualization of the Mucosa Before Endoscopy: A Prospective, Double Blinded, Randomized Controlled Trial.

Cao L, Zheng F, Wang D, Chen L, Feng X, Zhou Z Clin Transl Gastroenterol. 2023; 15(2):e00625.

PMID: 37581331 PMC: 10887445. DOI: 10.14309/ctg.0000000000000625.


[Recent research on the application of defoamers in children undergoing digestive endoscopy].

Gao J, Liu H Zhongguo Dang Dai Er Ke Za Zhi. 2023; 25(5):541-545.

PMID: 37272183 PMC: 10247202. DOI: 10.7499/j.issn.1008-8830.2301074.